MYCL vs. IBDR

Last updated Jun 4, 2026

MYCL (State Street My2032 Corporate Bond ETF) and IBDR (iShares iBonds Dec 2026 Term Corporate ETF) are both Corporate Bonds funds. MYCL is actively managed, while IBDR is passively managed. Over the past year, MYCL returned 6.13% vs 4.38% for IBDR. At a 0.44 correlation, their price movements are largely independent. MYCL charges 0.15%/yr vs 0.10%/yr for IBDR.

Performance

MYCL vs. IBDR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in State Street My2032 Corporate Bond ETF (MYCL) and iShares iBonds Dec 2026 Term Corporate ETF (IBDR). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, MYCL achieves a 0.19% return, which is significantly lower than IBDR's 1.44% return.

MYCL

• 1D: -0.24%
• 1M: 0.10%
• YTD: 0.19%
• 6M: 0.17%
• 1Y: 6.13%
• 3Y*: —
• 5Y*: —
• 10Y*: —

IBDR

• 1D: -0.04%
• 1M: 0.25%
• YTD: 1.44%
• 6M: 1.80%
• 1Y: 4.38%
• 3Y*: 5.07%
• 5Y*: 1.50%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

MYCL vs. IBDR - Yearly Performance Comparison

	2026 (YTD)	2025	2024
MYCL State Street My2032 Corporate Bond ETF	0.19%	9.03%	-2.98%
IBDR iShares iBonds Dec 2026 Term Corporate ETF	1.44%	4.99%	0.42%

Correlation

The correlation between MYCL and IBDR is 0.15, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.15
Correlation (All Time) Calculated using the full available price history since Sep 25, 2024	0.44

Over the past year, the correlation between MYCL and IBDR has dropped to 0.15 - well below their long-term average of 0.44, suggesting their price drivers have been diverging.

Return for Risk

MYCL vs. IBDR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MYCL

MYCL Risk / Return Rank: 47
MYCL Sharpe Ratio Rank: 47
MYCL Sortino Ratio Rank: 49
MYCL Omega Ratio Rank: 46
MYCL Calmar Ratio Rank: 46
MYCL Martin Ratio Rank: 45

IBDR

IBDR Risk / Return Rank: 99
IBDR Sharpe Ratio Rank: 99
IBDR Sortino Ratio Rank: 99
IBDR Omega Ratio Rank: 99
IBDR Calmar Ratio Rank: 99
IBDR Martin Ratio Rank: 99

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MYCL vs. IBDR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for State Street My2032 Corporate Bond ETF (MYCL) and iShares iBonds Dec 2026 Term Corporate ETF (IBDR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	MYCL	IBDR	Difference
Sharpe ratio Return per unit of total volatility	1.60	6.93	-5.33
Sortino ratio Return per unit of downside risk	2.38	14.59	-12.22
Omega ratio Gain probability vs. loss probability	1.28	3.40	-2.12
Calmar ratio Return relative to maximum drawdown	2.22	53.28	-51.06
Martin ratio Return relative to average drawdown	7.16	185.24	-178.08
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

MYCL vs. IBDR - Sharpe Ratio Comparison

The current MYCL Sharpe Ratio is 1.60, which is lower than the IBDR Sharpe Ratio of 6.93. The chart below compares the historical Sharpe Ratios of MYCL and IBDR, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	MYCL	IBDR	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.60	6.93	-5.33
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	0.44	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.72	0.61	+0.11

Drawdowns

MYCL vs. IBDR - Drawdown Comparison

The maximum MYCL drawdown since its inception was -4.39%, smaller than the maximum IBDR drawdown of -16.06%. Use the drawdown chart below to compare losses from any high point for MYCL and IBDR.

Drawdown Indicators

	MYCL	IBDR	Difference
Max Drawdown Largest peak-to-trough decline	-4.39%	-16.06%	+11.67%
Max Drawdown (1Y) Largest decline over 1 year	-2.77%	-0.08%	-2.69%
Max Drawdown (3Y) Largest decline over 3 years	—	-1.08%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-13.13%	—
Current Drawdown Current decline from peak	-1.51%	-0.04%	-1.47%
Average Drawdown Average peak-to-trough decline	-1.06%	-2.84%	+1.78%
Ulcer Index Depth and duration of drawdowns from previous peaks	0.86%	0.02%	+0.84%

Volatility

MYCL vs. IBDR - Volatility Comparison

State Street My2032 Corporate Bond ETF (MYCL) has a higher volatility of 1.24% compared to iShares iBonds Dec 2026 Term Corporate ETF (IBDR) at 0.15%. This indicates that MYCL's price experiences larger fluctuations and is considered to be riskier than IBDR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	MYCL	IBDR	Difference
Volatility (1M) Calculated over the trailing 1-month period	1.24%	0.15%	+1.09%
Volatility (6M) Calculated over the trailing 6-month period	2.82%	0.34%	+2.48%
Volatility (1Y) Calculated over the trailing 1-year period	3.85%	0.64%	+3.21%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	4.88%	3.40%	+1.48%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	4.88%	4.86%	+0.02%

MYCL vs. IBDR - Expense Ratio Comparison

MYCL has a 0.15% expense ratio, which is higher than IBDR's 0.10% expense ratio. However, both funds are considered low-cost compared to the broader market, where average expense ratios usually range from 0.3% to 0.9%.

Dividends

MYCL vs. IBDR - Dividend Comparison

MYCL's dividend yield for the trailing twelve months is around 4.66%, more than IBDR's 4.13% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
IBDR iShares iBonds Dec 2026 Term Corporate ETF	4.13%	4.20%	4.13%	3.41%	2.44%	2.11%	2.61%	3.25%	3.56%	3.22%	0.86%
MYCL State Street My2032 Corporate Bond ETF	4.66%	4.60%	1.27%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both MYCL and IBDR in my portfolio?

MYCL and IBDR have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, MYCL or IBDR?

MYCL has higher volatility (1.24%) compared to IBDR (0.15%). In terms of maximum drawdown, MYCL dropped -4.39% vs IBDR's -16.06%.

Which ETF is better, MYCL or IBDR?

On 1-year performance, MYCL leads with 6.13% vs 4.38% for IBDR. On fees, IBDR is cheaper at 0.10% per year. On volatility, IBDR has been the lower-risk option at 0.15%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, MYCL or IBDR?

Over the 1-year period, MYCL has performed better with a 6.13% return vs 4.38%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, MYCL or IBDR?

IBDR is cheaper with a 0.10% expense ratio, compared with 0.15% for MYCL.

Which ETF pays a higher dividend yield, MYCL or IBDR?

MYCL has the higher dividend yield at 4.66%, compared with 4.13% for IBDR.

What is the main difference between MYCL and IBDR?

They also come from different issuers: State Street and iShares. Their fees differ too: 0.15% for MYCL and 0.10% for IBDR.

Which has better risk-adjusted returns?

IBDR currently has the higher Sharpe Ratio (6.93 vs 1.60), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.